Association between atherogenicity indices and prediabetes: a 5-year retrospective cohort study in a general Chinese physical examination population
- PMID: 40399916
- PMCID: PMC12096774
- DOI: 10.1186/s12933-025-02768-8
Association between atherogenicity indices and prediabetes: a 5-year retrospective cohort study in a general Chinese physical examination population
Abstract
Background and objective: Atherogenicity indices have emerged as promising markers for cardiometabolic disorders, yet their relationship with prediabetes risk remains unclear. This study aimed to comprehensively evaluate the associations between six atherogenicity indices and prediabetes risk in a Chinese population, and explore the predictive value of these atherosclerotic parameters for prediabetes.
Methods: This retrospective cohort study included 97,151 participants from 32 healthcare centers across China, with a median follow-up of 2.99 (2.13, 3.95) years. Six atherogenicity indices were calculated: Castelli's Risk Index-I (CRI-I), Castelli's Risk Index-II (CRI-II), Atherogenic Index of Plasma (AIP), Atherogenic Index (AI), Lipoprotein Combine Index (LCI), and Cholesterol Index (CHOLINDEX). To address the natural relationships between the atherogenicity indices and risk of prediabetes, we applied Cox proportional hazards regression with cubic spline functions and smooth curve fitting, using a recursive algorithm to calculate inflection points. Machine learning approach (XGBoost and Boruta methods) to address the high collinearity among indices and assess their relative importance, combined with time-dependent ROC analysis to evaluate the predictive performance at 3-, 4-, and 5-year follow-up.
Results: During follow-up, 11,199 participants developed prediabetes (incidence rate: 3.71 per 100 person-years). Significant nonlinear associations were observed between all atherogenicity indices and prediabetes risk. Through Z-score standardization of atherogenicity indices and comprehensive Cox proportional hazards regression and advanced machine learning techniques, we identified AIP as the most significant predictor of prediabetes [HR = 1.057 (95% CI 1.035-1.080, P < 0.0001)], with LCI emerging as a secondary important marker [HR = 1.020 (95% CI 1.002-1.038, P = 0.0267)]. Our innovative XGBoost and Boruta analysis uniquely validated these findings, providing robust evidence of AIP and LCI's critical role in prediabetes risk assessment. Time-dependent ROC analysis further validated these findings, with LCI and AIP demonstrating comparable discrimination, with overlapping AUC ranges of 0.5952-0.6082. Notably, the combined indices model achieved enhanced predictive performance (AUC: 0.6753) compared to individual indices, suggesting the potential benefit of using multiple atherogenicity indices for prediabetes risk prediction.
Conclusion: This study identifies statistically significant associations between atherogenicity indices and prediabetes risk, highlighting their nonlinear relationships and combined effects. While the predictive performance of these indices is modest (AUC 0.55-0.68), these findings may contribute to improved risk stratification when incorporated into comprehensive assessment strategies.
Keywords: Atherogenicity indices; Cohort study; Machine learning; Nonlinear relationship; Prediabetes; Risk prediction.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethical approval and consent to participate: The studies involving human participants were reviewed and approved by the Rich Healthcare Group Review Board. The data were retrospectively collected, and the information gathered is anonymized. Given the observational nature of the study, the Rich Healthcare Group Review Board waived the requirement for informed consent, as previously reported [30, 39]. Consent for publication: Not applicable. Competing interests: The authors declare that they have no competing interests.
Figures





References
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
- SZXK009/Shenzhen Key Medical Discipline Construction Fund
- SZXK009/Shenzhen Key Medical Discipline Construction Fund
- SZSM202211013/Sanming Project of Medicine in Shenzhen
- SZSM202211013/Sanming Project of Medicine in Shenzhen
- SZXJ2017031/Discipline Construction Ability Enhancement Project of the Shenzhen Municipal Health Commission